Overview

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of LATISSE® (bimatoprost 0.03%) in the augmentation of eyelashes in Korean women.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost